Use of thalidomide for severe recurrent aphthous stomatitis: a multicenter cohort analysis.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 20453604)

Published in Medicine (Baltimore) on May 01, 2010

Authors

Muriel Hello1, Sébastien Barbarot, Sylvie Bastuji-Garin, Jean Revuz, Olivier Chosidow

Author Affiliations

1: Department of Dermatology, CHU Hôtel-Dieu, Nantes, France. muriel.hello@wanadoo.fr

Articles citing this

Urban legends: recurrent aphthous stomatitis. Oral Dis (2011) 1.68

Treatment of recurrent aphthous stomatitis. A literature review. J Clin Exp Dent (2014) 0.91

Recurrent aphthous stomatitis. Dent Clin North Am (2014) 0.85

Update on the diagnosis and management of Behçet's disease. Open Access Rheumatol (2014) 0.75

Articles by these authors

Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA (2002) 7.04

Intermittent subglottic secretion drainage and ventilator-associated pneumonia: a multicenter trial. Am J Respir Crit Care Med (2010) 3.25

Bedbugs and infectious diseases. Clin Infect Dis (2011) 3.09

Respiratory weakness is associated with limb weakness and delayed weaning in critical illness. Crit Care Med (2007) 2.96

Sixty-three cases of Mycobacterium marinum infection: clinical features, treatment, and antibiotic susceptibility of causative isolates. Arch Intern Med (2002) 2.73

Does ICU-acquired paresis lengthen weaning from mechanical ventilation? Intensive Care Med (2004) 2.35

Presence and severity of intensive care unit-acquired paresis at time of awakening are associated with increased intensive care unit and hospital mortality. Crit Care Med (2009) 2.31

Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol (2008) 2.29

NF-1Score: a prediction score for internal neurofibromas in neurofibromatosis-1. J Invest Dermatol (2010) 2.25

IgG4-related skin disease successfully treated by thalidomide: a report of 2 cases with emphasis on pathological aspects. JAMA Dermatol (2013) 1.98

Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients. J Invest Dermatol (2002) 1.96

Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression. Arch Dermatol (2003) 1.94

Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients. Brain (2003) 1.85

Prehospital standardization of medical airway management: incidence and risk factors of difficult airway. Acad Emerg Med (2006) 1.76

Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: a prospective study of 54 patients. J Am Acad Dermatol (2003) 1.74

Mutations in FAM111B cause hereditary fibrosing poikiloderma with tendon contracture, myopathy, and pulmonary fibrosis. Am J Hum Genet (2013) 1.70

Incidence of new-onset and flare of preexisting psoriasis during rituximab therapy for rheumatoid arthritis: data from the French AIR registry. J Rheumatol (2012) 1.69

Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity. J Am Acad Dermatol (2009) 1.68

Topical ivermectin--a step toward making head lice dead lice? N Engl J Med (2012) 1.67

Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross-sectional study. J Invest Dermatol (2012) 1.59

Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009) 1.57

Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients. Cochrane Database Syst Rev (2014) 1.56

Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Pediatrics (2009) 1.53

Prognostic value of skin manifestations of infective endocarditis. JAMA Dermatol (2014) 1.51

Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis. J Rheumatol (2002) 1.50

NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype. Hum Mutat (2010) 1.47

Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation. Crit Care Med (2014) 1.46

Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study. J Clin Oncol (2011) 1.45

Risk factors for Gram-negative bacterial infections in febrile neutropenia. Haematologica (2005) 1.44

Back and face involvement in hidradenitis suppurativa. Dermatology (2010) 1.41

Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure. Arch Dermatol (2009) 1.39

Clinical heterogeneity of duchenne muscular dystrophy (DMD): definition of sub-phenotypes and predictive criteria by long-term follow-up. PLoS One (2009) 1.36

The management of skin reactions in cancer patients receiving epidermal growth factor receptor targeted therapies. J Dtsch Dermatol Ges (2005) 1.31

Sedation algorithm in critically ill patients without acute brain injury. Crit Care Med (2005) 1.30

A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study. J Invest Dermatol (2009) 1.26

Typology of the primary outcome construction in dermatology: a systematic review of published randomized controlled trials. J Invest Dermatol (2012) 1.23

Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1. Hum Mol Genet (2009) 1.21

Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980-2006 in France. Orphanet J Rare Dis (2011) 1.16

Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response. Sci Transl Med (2013) 1.15

Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications. Urol Oncol (2004) 1.15

Toward the global control of human scabies: introducing the International Alliance for the Control of Scabies. PLoS Negl Trop Dis (2013) 1.14

Neurological disorders in patients with bullous pemphigoid. Dermatology (2007) 1.14

Scabies: a suitable case for a global control initiative. Curr Opin Infect Dis (2013) 1.13

No evidence of Bartonella quintana but detection of Acinetobacter baumannii in head lice from elementary schoolchildren in Paris. Comp Immunol Microbiol Infect Dis (2011) 1.13

French people and skin diseases: results of a survey using a representative sample. Arch Dermatol (2003) 1.11

Cutaneous Invasive Aspergillosis: Retrospective Multicenter Study of the French Invasive-Aspergillosis Registry and Literature Review. Medicine (Baltimore) (2015) 1.11

Propranolol for treatment of ulcerated infantile hemangiomas. J Am Acad Dermatol (2011) 1.10

Scabies in healthcare settings. Curr Opin Infect Dis (2010) 1.09

Successsful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient. Clin Infect Dis (2003) 1.09

Mortality of patients with heatstroke admitted to intensive care units during the 2003 heat wave in France: a national multiple-center risk-factor study. Crit Care Med (2006) 1.07

Living with acne. A study of adolescents' personal experiences. Dermatology (2007) 1.07

Clinical practice. Lichen planus. N Engl J Med (2012) 1.05

Intravitreal ranibizumab for choroidal neovascularization complicating pathologic myopia. Retina (2010) 1.05

Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: a cohort study of 703 patients. Am J Med Genet A (2005) 1.05

Pyemotes ventricosus dermatitis, southeastern France. Emerg Infect Dis (2008) 1.04

Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. J Am Acad Dermatol (2006) 1.04

Dressings for acute and chronic wounds: a systematic review. Arch Dermatol (2007) 1.04

Prediction of survival for patients with bullous pemphigoid: a prospective study. Arch Dermatol (2005) 1.04

Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis. J Invest Dermatol (2006) 1.04

Genotypic influences on severity of exudative age-related macular degeneration. Invest Ophthalmol Vis Sci (2009) 1.03

Reliability of the histopathologic diagnosis of malignant melanoma in childhood. Arch Dermatol (2002) 1.02

Hormonal status in protracted critical illness and in-hospital mortality. Crit Care (2011) 1.01

Paraneoplastic acral vascular syndrome: epidemiologic features, clinical manifestations, and disease sequelae. J Am Acad Dermatol (2002) 1.01

Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy. Clin Infect Dis (2003) 1.00

Pemphigus in elderly adults: clinical presentation, treatment, and prognosis. J Am Geriatr Soc (2012) 1.00

Failure to achieve glycemic control despite intensive insulin therapy in a medical ICU: incidence and influence on ICU mortality. Intensive Care Med (2007) 0.98

Rickettsia sibirica mongolitimonae in traveler from Egypt. Emerg Infect Dis (2010) 0.97

Acne as seen by adolescents: results of questionnaire study in 852 French individuals. Acta Derm Venereol (2011) 0.97

Two observations raising questions about risk factors of cutaneous necrosis induced by terlipressin (Glypressin). Dermatology (2009) 0.97

Fatal disseminated Acanthamoeba lenticulata infection in a heart transplant patient. Emerg Infect Dis (2007) 0.97

Impact of invasive fungal disease on the chemotherapy schedule and event-free survival in acute leukemia patients who survived fungal disease: a case-control study. Haematologica (2010) 0.95

Clinical risk factors for mortality in patients with neurofibromatosis 1: a cohort study of 378 patients. Arch Dermatol (2003) 0.95

Infantile acne: a retrospective study of 16 cases. Pediatr Dermatol (2008) 0.94

Involvement of the leptin receptor in the immune response in intestinal cancer. Cancer Res (2008) 0.94

Thalidomide: an old drug with new clinical applications. Expert Opin Drug Saf (2004) 0.93

A three-year-analysis of fixed drug eruptions in hospital settings in France. Eur J Dermatol (2010) 0.93

Angiographic and optical coherence tomography characteristics of recent myopic choroidal neovascularization. Am J Ophthalmol (2013) 0.93

Severe herpes virus (HSV-2) infection in two patients with myelodysplasia and undetectable NK cells and plasmacytoid dendritic cells in the blood. J Clin Virol (2004) 0.92

Bedbugs and healthcare-associated dermatitis, France. Emerg Infect Dis (2009) 0.92

Topical retapamulin ointment, 1%, versus sodium fusidate ointment, 2%, for impetigo: a randomized, observer-blinded, noninferiority study. Dermatology (2007) 0.92

Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients. Medicine (Baltimore) (2008) 0.91

A meta-analysis to assess the efficacy of oral antiviral treatment to prevent genital herpes outbreaks. J Am Acad Dermatol (2007) 0.91

Management of scabies. Skin Therapy Lett (2012) 0.91

A multistep voriconazole-related phototoxic pathway may lead to skin carcinoma: results from a French nationwide study. Clin Infect Dis (2013) 0.90

Accuracy of external ventricular drainage catheter placement. Acta Neurochir (Wien) (2011) 0.89

Prevalence of inherited ichthyosis in France: a study using capture-recapture method. Orphanet J Rare Dis (2014) 0.89

Risk factors for erysipelas of the leg in Tunisia: a multicenter case-control study. Dermatology (2006) 0.88

Risk of herpes zoster in patients receiving anti-TNF-α in the prospective French RATIO registry. J Invest Dermatol (2011) 0.88

Efalizumab-induced bullous pemphigoid. J Am Acad Dermatol (2010) 0.88

Does the site of magnetic resonance imaging abnormalities match the site of recent-onset inflammatory back pain? The DESIR cohort. Ann Rheum Dis (2012) 0.88

Large congenital melanocytic nevi: therapeutic management and melanoma risk: a systematic review. J Am Acad Dermatol (2012) 0.87

Lack of efficacy of abatacept in axial spondylarthropathies refractory to tumor-necrosis-factor inhibition. Joint Bone Spine (2011) 0.86

Hormonal status and ICU-acquired paresis in critically ill patients. Intensive Care Med (2010) 0.86

Improving participation in colorectal cancer screening: targets for action. Prev Med (2012) 0.86

In situ immunophenotype of the inflammatory infiltrate in eosinophilic fasciitis. J Rheumatol (2003) 0.86